Colorectal cancer care in the COVID-19 era: outcomes from a 'mixed site' model

The COVID-19 pandemic has presented many challenges to colorectal cancer (CRC) care. Many organisations opted to perform CRC resections in 'cold' sites. Infrastructure in Northumbria Healthcare NHS Foundation Trust (NHCT) necessitated co-locating CRC care with 'hot' COVID streams but with additional precautions. This study aimed to evaluate that approach for a consecutive series of CRC cases, diagnosed before and during the COVID-19 pandemic. A prospectively populated data set of CRC patients diagnosed between 1 April 2019 and 30 September 2020 was used. Patients presenting before 1 April 2020 were considered 'pre-COVID' and those presenting subsequently as 'COVID era'. Some 344 cases were diagnosed in the 12 months 'pre-COVID' and 166 in the 6 months of the 'COVID era'. The median numbers of days from referral to diagnosis (21 vs 20, =0.373) and operation (63 vs 61, =0.208) were unchanged. The 'COVID era' saw an increase in the proportion of radiological diagnoses (39.5% vs 53.0%, =0.004) with an associated decrease in endoscopic diagnoses (56.7% vs 45.8%, =0.021). Rates of inoperable (1.5% vs 1.2%, =0.821), obstructing (11.0% vs 16.2%, =0.272) and perforated tumours (0.6% vs 1.5%, =0.492) remained the same. One patient developed COVID-19 perioperatively. Rates of laparoscopic operation (59.5% vs 61.8%, =0.751), anastomotic leak (6.4% vs 5.9%, =0.891), re-operative surgery (10.4% vs 4.4%, =0.138), primary stoma (40.5% vs 32.4%, =0.244) and 90-day mortality (0.6% vs 1.5%, =0.492) did not change. With appropriate infection control measures, it may be safe to continue providing standard elective and urgent CRC care without access to a 'COVID clean' site.